Corvus Pharma Com (CRVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRVS | BMY | AMGN | GILD | REGN |
| Company | Corvus Pharma Com | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.0200 | 78.70 | 246.26 | 62.31 | 597.56 |
| High | 1.0600 | 79.17 | 247.10 | 62.97 | 607.41 |
| Low | 0.9654 | 77.99 | 243.72 | 61.92 | 590.01 |
| Last | 1.0200 | 78.28 | 245.43 | 62.48 | 597.62 |
| Change | -0.0100 | -0.42 | +1.92 | +0.27 | +3.20 |
| % Change | -0.97% | -0.53% | +0.79% | +0.43% | +0.54% |
| Volume | 267,500 | 8,711,000 | 2,608,700 | 5,789,700 | 531,500 |
| 20-Day Average Volume | 285,135 | 13,170,465 | 3,656,515 | 7,831,345 | 804,855 |
| Previous Close | 1.0300 | 78.70 | 243.51 | 62.21 | 594.42 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.0300 | 75.84 | 242.18 | 61.37 | 594.17 |
| 20-Day Raw Stochastic | 53.99% | 73.99% | 55.97% | 65.02% | 44.37% |
| 20-Day Relative Strength | 46.31% | 57.94% | 53.04% | 52.64% | 44.56% |
| Weighted Alpha | -79.61 | +23.42 | +3.58 | -10.14 | -2.79 |
| Today's Opinion | 100% Sell | 88% Buy | 72% Buy | 16% Sell | 56% Sell |
| Previous Opinion | 100% Sell | 88% Buy | 56% Buy | 16% Sell | 72% Sell |
| Last Month's Opinion | 100% Sell | 80% Buy | 88% Buy | 24% Sell | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.92% since 06/22/22 | +2.26% since 06/22/22 | +2.20% since 06/22/22 | +1.58% since 06/22/22 | +1.84% since 06/22/22 |
| Low | 0.7501 on 06/24/22 | 76.56 on 06/23/22 | 240.91 on 06/23/22 | 61.75 on 06/23/22 | 589.98 on 06/23/22 |
| High | 1.1500 on 06/24/22 | 80.59 on 06/27/22 | 247.58 on 06/28/22 | 63.53 on 06/27/22 | 613.15 on 06/24/22 |
| 1-Month | |||||
| %Chg | -5.56% since 05/27/22 | +2.81% since 05/27/22 | -3.85% since 05/27/22 | -3.58% since 05/27/22 | -13.74% since 05/27/22 |
| Low | 0.7501 on 06/24/22 | 71.71 on 06/16/22 | 229.49 on 06/17/22 | 57.17 on 06/14/22 | 538.01 on 06/14/22 |
| High | 1.2500 on 06/08/22 | 80.59 on 06/27/22 | 257.97 on 06/01/22 | 65.34 on 06/01/22 | 692.80 on 05/31/22 |
| 3-Month | |||||
| %Chg | -37.04% since 03/29/22 | +6.90% since 03/29/22 | +1.61% since 03/29/22 | +3.22% since 03/29/22 | -14.43% since 03/29/22 |
| Low | 0.7501 on 06/24/22 | 71.71 on 06/16/22 | 227.32 on 05/02/22 | 57.17 on 06/14/22 | 538.01 on 06/14/22 |
| High | 2.1100 on 04/05/22 | 80.59 on 06/27/22 | 258.45 on 04/11/22 | 65.46 on 05/26/22 | 747.42 on 04/08/22 |
| 6-Month | |||||
| %Chg | -56.41% since 12/29/21 | +25.67% since 12/29/21 | +7.83% since 12/29/21 | -15.15% since 12/29/21 | -7.67% since 12/29/21 |
| Low | 0.7501 on 06/24/22 | 60.86 on 01/06/22 | 214.39 on 02/24/22 | 57.17 on 06/14/22 | 538.01 on 06/14/22 |
| High | 2.5500 on 12/30/21 | 80.59 on 06/27/22 | 258.45 on 04/11/22 | 74.12 on 12/30/21 | 747.42 on 04/08/22 |
| Key Statistics | |||||
| Market Capitalization, $K | 47,951 | 167,557,328 | 130,083,040 | 78,030,808 | 64,517,752 |
| Shares Outstanding, K | 46,554 | 2,129,064 | 534,200 | 1,254,313 | 108,539 |
| Annual Sales | 0 | 46,385,000,000 | 25,979,000,000 | 27,305,000,000 | 16,071,700,000 |
| Annual Net Income | -43,240,000 | 6,994,000,000 | 5,893,000,000 | 6,225,000,000 | 8,075,300,000 |
| Last Quarter Sales | 0 | 11,648,000,000 | 6,238,000,000 | 6,590,000,000 | 2,965,100,000 |
| Last Quarter Net Income | -8,300,000 | 1,278,000,000 | 1,476,000,000 | 19,000,000 | 973,500,000 |
| 60-Month Beta | 1.08 | 0.49 | 0.57 | 0.37 | 0.25 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.18 on 05/05/22 | 1.96 on 04/29/22 | 4.25 on 04/27/22 | 2.12 on 04/28/22 | 11.49 on 05/04/22 |
| Latest Earnings Date | 08/01/22 | 07/27/22 | 08/02/22 | 08/04/22 | 08/04/22 |
| Most Recent Dividend | N/A | 0.540 on 06/30/22 | 1.940 on 05/16/22 | 0.730 on 06/14/22 | N/A |
| Next Ex-Dividends Date | N/A | 06/30/22 | 05/16/22 | 06/14/22 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 10.36 | 13.86 | 8.57 | 7.67 |
